Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

122 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Purple Biotech Debuts Scientific Advisory Board
GL
Purple Biotech Debuts Scientific Advisory Board
AQ
Purple Biotech Ltd. Debuts Scientific Advisory Board
CI
Purple Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
PU
AAON : Annual Report (Form ARS)
PU
“There Can Be Only One”: The Highlander Principle of Data Science
PU
SCREAMING EAGLE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)
AQ
Screaming Eagle Acquisition Corp. Announces Executive Appointments
CI
Empire BlueCross BlueShield and Crain’s New York Business Award 25 “Whole Health Heroes”
BU
GINKGO BIOWORKS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
HYCU® Leads Public Service Initiative for Ransomware Recovery with R-Score
GL
Aura Biosciences : Assembles New Bladder Cancer Focused Scientific Advisory Board
BU
International Folk Art Market Announces Artist Lineup for 2021 Summer Market
GL
NexImmune Announces Formation of Scientific Advisory Board
GL
NexImmune, Inc. Announces Formation of Scientific Advisory Board
CI
AAON : Annual Report (SEC Filing - ARS)
PU
China CITIC Bank : ANNOUNCEMENT PROPOSED APPOINTMENT OF THE DIRECTORS FOR THE SIXTH SESSION OF THE BOARD OF DIRECTORS
PU
SOARING EAGLE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)
AQ
Soaring Eagle Acquisition Corp. Announces Board and Committee Appointments
CI
David Lynn Joins White Oak Healthcare Finance as President and Chief Investment Officer of White Oak Healthcare MOB REIT
BU
Novartis : expands Africa Sickle Cell Disease program to Uganda and Tanzania
AQ
DRAFTKINGS INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
DraftKings, Inc. and SBTech Limited completed the acquisition of Diamond Eagle Acquisition Corp. in a reverse merger transaction.
CI
Kitov Pharma : SEC Filing (424B4) - Supplemental Prospectus
PU
Diamond Eagle Acquisition : SEC Filing (S-4/A) - Registration of Securities issued in Business Combination Transaction (Amendment)
PU
Kitov Pharma : SEC Filing (F-1/A)
PU
Kitov Pharma : Announces Appointment of Bertrand Liang, M.D., Ph.D., as Chief Medical Officer
AQ
Kitov Pharma : Announces Appointment of Bertrand Liang, M.D., Ph.D., as Chief Medical Officer
AQ
DraftKings : to Become Public Company, Creating the Only Vertically-Integrated U.S.-based Sports Betting and Online Gaming Company
BU
DraftKings, Inc. and SBTech Limited entered into a non-binding term sheet to acquire Diamond Eagle Acquisition Corp. in a reverse merger transaction.
CI
Hashchain Technology : Announces Extension to Defintive Agreement and Provides update on Proposed Reverse Takeover Transaction with Digihost International, Inc.
AQ
Fingerprints and finances: next Wells Fargo CEO will be under regulatory microscope
RE
Physicians’ Education Resource :® to Present 9 Satellite Symposia at 2019 ASCO Annual Meeting
BU
Transcript : GCI Liberty, Inc., Qurate Retail Group, Inc., Qurate Retail, Inc., Q1 2019 Earnings Call, May 10, 2019
Transcript : Atara Biotherapeutics, Inc., Q1 2019 Earnings Call, May 09, 2019
Transcript : Wells Fargo & Company - Shareholder/Analyst Call
Atara Biotherapeutics to Participate in Upcoming Conferences
GL
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Progress
GL
High-Profile Authors at Barnes & Noble in February: Chris Christie, Angie Thomas, Meg Wolitzer, and Many More
BU
Transcript : Atara Biotherapeutics, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-08-2019 10:30 AM
Puretech Health : Bristol-Myers Squibb and PureTech’s Vedanta Biosciences Announce New Immuno-Oncology Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers
PU
Bristol-Myers Squibb : and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers
BU
Atara Biotherapeutics Highlights Next-Generation and Off-the-Shelf, Allogeneic CAR T Technologies and Pipeline
GL
Transcript : Atara Biotherapeutics, Inc. - Shareholder/Analyst Call
Atara Biotherapeutics Announces Third Quarter 2018 Financial Results and Recent Operational Progress
GL
Transcript : Quess Corp Limited, Q2 2019 Earnings Call, Oct 26, 2018
Wells Fargo touts good deeds to get back in lawmakers' good graces
RE
Nigerian Federal Ministry of Health to Launch Pilot Cancer Drug Access Program with BIO Ventures for Global Health
BU
Transcript : Atara Biotherapeutics, Inc. Presents at Morgan Stanley 16th Annual Global Healthcare Conference, Sep-12-2018 02:15 PM
Atara Biotherapeutics Announces Second Quarter 2018 Financial Results and Recent Operational Progress
GL
No results for this search
  1. Stock Market
  2. Advanced search
  3. Isaac Sloan
  4. News